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Abstract Reperfusion may cause intramyocardial
hemorrhage (IMH) by extravasation of erythrocytes
through severely damaged endothelial walls. The
purpose of the study was to evaluate the clinical
significance of IMH in relation to infarct size, micro-
vascular obstruction (MVO) and function in patients
after primary percutaneous intervention. Forty-five
patients underwent cardiovascular MR imaging (CMR)
1 week and 4 months after primary stenting for a first
acute myocardial infarction. T2-weighted spin-echo
imaging (T2W) was used to assess infarct related edema
and IMH, and delayed enhancement (DE) was used to
assess infarct size and MVO. Cine CMR was used to
assess left ventricular volumes and function at baseline
and at 4 months follow-up. In 22 (49%) patients, IMH
was detected as areas of attenuated signal in the core of
the high signal intensity region on T2W images. Patients
with IMH had larger infarcts, higher left ventricular
volumes and lower ejection fraction. Contrast-to-noise
ratio (CNR) between hyperintense periphery and the
hypo-intense core of the T2W ischemic area correlated
to peak CKMB, total infarct size and MVO size. Using
univariable analysis, CNR predicted ejection fraction
at baseline (b = -0.62, P = 0.003) and follow-up
(b = -0.84, P \ 0.001). However, after multivariable
analysis, baseline ejection fraction and presence of
MVO were the only parameters that predicted functional
changes at follow-up. IMH was found in the majority of
patients with MVO after reperfused myocardial infarc-
tion. It was closely related to markers of infarct size,
MVO and function, but did not have prognostic
significance beyond MVO.
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Introduction
Timely reperfusion is the only way to preserve
ischemic myocardium in acute myocardial infarction.
However, reperfusion also induces new pathological
changes that were not seen in the pre-interventional
era [1]. Microvascular obstruction (MVO) or no-
reflow refers to the small vessel changes that prevent
adequate tissue perfusion despite a revascularized and
patent epicardial coronary artery [2, 3]. Although
MVO is related to infarct size, it is an independent
and powerful predictor of adverse outcome [4, 5].
Reperfusion may also cause intramyocardial hemor-
rhage (IMH) by extravasation of erythrocytes through
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severely damaged endothelial walls [6, 7]. IMH can
be visualized by T2-weighted CMR because break-
down products of hemoglobin are paramagnetic and
influence regional magnetic tissue properties [8, 9].
Previous studies found IMH in about one-third of
patients and suggested a relation with more severe
myocardial injury and MVO [10, 11]. However, the
exact significance of IMH and its relation to MVO
remain unclear.
This study was undertaken to further evaluate
presence and clinical significance of IMH by explor-
ing its relation to infarct size, MVO and function in
patients after primary coronary angioplasty for acute
myocardial infarction.
Methods
Patients
All patients gave informed consent to the study
protocol, which was approved by the local ethics
committee. Patients were considered study candidates
when admitted with a first ST-elevation acute myo-
cardial infarction treated with successful primary
coronary angioplasty (PCI) with stent implantation,
defined as thrombolysis in myocardial infarction
(TIMI) flow grade 2 or 3. Patients with hemodynamic
instability or (relative) contraindications for CMR
were excluded.
Cardiac magnetic resonance imaging protocol
All examinations were performed on a 1.5-T clinical
scanner (Sonata/Symphony, Siemens, Erlangen, Ger-
many) using a phased array cardiac receiver coil. The
baseline scan was scheduled between 2 and 9 days
after reperfusion and follow-up at 4 months. ECG-
gated images were acquired during end-expiration
breath holding. Segmented steady state free precession
cine imaging (average voxel size 1.6 9 1.9 9 5 mm3,
temporal resolution 47 ms) was used to evaluate left
ventricular function in long axis views and full
coverage short axis views (interslice gap 5 mm). Prior
to contrast injection, breath-hold, segmented T2-
weighted spin-echo imaging (T2W) (STIR, TR =
2 9 RR-interval, TE 64 ms, average voxel size
1.4 9 1.9 9 7 mm3) was performed to visualize
infarct related edema and hemorrhage. Three long
axis views and a short axis view at the core of the
infarct, defined as the short axis slice position with the
largest circumferential amount of wall motion abnor-
malities were acquired [12]. An image normalisation
filter was used to correct for coil inhomogeneity.
Delayed enhancement (DE) images were acquired
using a segmented inversion recovery gradient-echo
pulse sequence (average voxel size 1.4 9 1.7 9
5 mm3, trigger pulse 2, inversion time 250–300 ms)
12–15 min after i.v. administration of 0.2 mmol/kg
gadolinium-DTPA in short axis views with slice
positions copied from the cine series.
Analysis
All CMR data were analysed on a separate workstation
using dedicated software (Mass version 2006beta,
Medis, Leiden, the Netherlands). Cine, T2W and
contrast images were analysed separately, and, during
analysis of one technique, the observers were blinded
to results of the other techniques as well as to other
clinical patient data. Endocardial and epicardial con-
tours were manually drawn on all end-diastolic and
end-systolic cine images to calculate normalised (body
surface area) left ventricular end-diastolic (EDV) and
end-systolic volumes (ESV), mass and ejection frac-
tion. T2W images were assessed qualitatively for the
presence of regional high signal intensity. IMH was
considered present on T2W if regions of low (atten-
uated) signal were seen within the high signal area.
Using the short axis view, the high signal intensity area
(T2W infarct area) was quantified after windowing the
images at mean ? 2 SD of the signal intensity (SI) of
remote, normal myocardium, and expressed as a
percentage of total slice area. IMH was included in
the calculation of T2W infarct area. An ellipsoid
region of interest (0.2–0.3 cm2) was placed in the
central part (core) of the T2W infarct, covering the
region with attenuated signal when present, and placed
in the middle of the hyperintense region in patients
without IMH. Regions of interest were also drawn in
the peripheral part (peri) of the T2W infarct area and in
remote, normal myocardium (Fig. 1). Signal-to-noise
ratio (SNR) was calculated as SNRcore = SIcore/
SDnoise, and SNRperi = SIperi/SDnoise and SNRnorm =
SInorm/SDnoise, respectively. Since no parallel imaging
was used, noise was calculated as the standard
deviation of a region of interest in background air,
divided by 0.7, taking into account the number of
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effective radiofrequency coils.[13] Contrast-to-noise
ratio (CNR) between the infarct periphery and core
was calculated as CNR = (SIperi - SIcore)/SDnoise.
DE images were analysed as previously described
[14]. Total infarct size was expressed as percentage of
total left ventricular mass. MVO was defined as any
region of hypoenhancement within the hyperen-
hanced, infarcted area, and was included in the
calculation of total infarct size. MVO size was
calculated by subtraction of the hyperenhanced area
from the total infarct size, and expressed as a
percentage of left ventricular mass (%). For direct
comparison of infarct extent with T2W images, infarct
area in the same slice position was quantified and
expressed as percentage of total slice area.
Statistical analysis
Data are expressed as mean ± SD for continuous
variables. The independent samples t test and Chi-
square test were used to compare subgroups. The
paired samples t test was used to evaluate changes in
left ventricular global parameters between baseline
and follow-up. Pearson’s correlation coefficients (r)
were calculated for the relation between CNR, peak
CKMB, total infarct size, MVO size and ejection
fraction. Univariable and multivariable linear regres-
sion analysis was used to evaluate the relation of
clinical (age, CKMB) and CMR parameters (total
infarct size, MVO, CNR) to ejection fraction and
their ability to predict changes at follow-up.
Results
Fifty consecutive patients were included in the study
protocol. T2W image quality was non-diagnostic in
both short axis and long axis views in 5 (10%) because
of artifacts or regional signal loss caused by cardiac or
respiratory motion. The remaining 45 patients had an
uncomplicated clinical course between both CMR
examinations. Mean time between admission and
baseline CMR was 5.1 ± 2.1 days. Mean total infarct
size was 17.6 ± 10.0% of total left ventricular mass.
Fig. 1 Edema,
hemorrhage, infarct and
microvascular obstruction.
High and homogeneous
T2W signal (a) in a patient
with subendocardial
anteroseptal infarction
without MVO (b).
Attenuated T2W signal
corresponding to
hemorrhage in the infarct
core (c) in a patient with
transmural inferoposterior
infarction with MVO (d).
Infarct area on T2W images
is larger than on DE images
in both patients. Borders of
the infarcted areas are
indicated by triangles, T2W
core by solid arrow, T2W
periphery by interrupted
arrow and MVO by asterisk
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MVO was identified on contrast images in 27 patients
(60%), and mean MVO size was 6.0 ± 8.4% of total
infarct size. Mean ejection fraction was 42 ± 10%,
and increased to 45 ± 10% at follow-up (P = 0.004).
Edema, hemorrhage and MVO
In all patients, T2W revealed a region of high signal
intensity in the distribution area of the infarct related
artery (Fig. 1). In almost half (22 of 45), areas of
varying size of lower signal intensity could be
identified in the central part of the area of high
signal intensity (Fig. 1). Baseline characteristics
according to presence of IMH are summarized in
Table 1.
All patients with IMH had MVO on contrast
images and only five patients with MVO did not have
IMH on T2W. At baseline, patients with IMH had
higher peak CKMB, larger total infarct size, larger
volumes and lower ejection fraction. At follow-up,
patients without IMH showed a significant improve-
ment in EDV (89 ± 22 vs. 83 ± 22 ml/m2, P =
0.05), ESV (49 ± 17 vs. 43 ± 15 ml/m2, P = 0.003)
and ejection fraction (46.4 ± 8.4 vs. 49.6 ± 8.0%,
P = 0.04). Patients with IMH showed a non-signif-
icant increase in EDV (104 ± 22 vs. 111 ± 29 ml/
m2, P = 0.076) and ESV (65 ± 19 vs. 67 ± 24 ml/
m2, P = 0.310), and a small, non-significant increase
in ejection fraction (38.9 ± 8.1 vs. 40.6 ± 8.5%,
P = 0.72).
SNR and CNR analysis
Five additional patients were excluded from further
signal intensity analysis because the short axis images
were of insufficient quality to calculate T2W infarct
area or SNR. In the remaining 40 patients, there was a
significant correlation between mean infarct area on
T2W images and on DE images (r = 0.73, P \
0.001), although the area was larger on T2W images:
49.3 ± 15% vs. 28.9 ± 15.7%, P \ 0.001 (Fig 1).
SNRperi was significantly higher than SNRcore in the
patients with MVO (29.4 vs. 20.6, P \ 0.001) but not
in patients without MVO (29.9 vs. 30.2, P = 0.68).
As a result, CNR was higher in patients with MVO
than in patients without MVO (8.8 ± 5.5 vs. 0.3 ±
3.5, P \ 0.001). CNR correlated significantly with
peak CKMB (r = 0.51, P = 0.001), total infarct size
(r = 0.57, P \ 0.001), and size of the MVO area
(r = 0.52, P \ 0.001).
Hemorrhage and ejection fraction
Using univariable analysis, CNR strongly predicted
ejection fraction at baseline (b = -0.62, P = 0.003)
and follow-up (b = -0.84, P \ 0.001), but not the
change over time (b = -0.22, P = 0.11). After multi-
variable analysis, infarct size remained the single
independent predictor of ejection fraction at baseline
(b = -0.69, P \ 0.001) and follow-up (b = -0.73,
P \ 0.001), whereas baseline ejection fraction and
presence of MVO were the only predictors of change
Table 1 Baseline characteristics according to absence (IMH-)
or presence (IMH?) of intramyocardial hemorrhage on T2W
images
IMH- IMH? P value
Number 23 22 NS
Age (SD) 59 ± 10 54 ± 10 NS
Male 21 19 NS
Diabetes 2 0 NS
Hypercholesterolemia 5 8 NS
Hypertension 6 6 NS
Smoking 14 14 NS
Infarct related artery
LAD 13 16 NS
LCx 3 3 NS
RCA 7 3 NS
Time to reperfusion (hours) 3.6 ± 3.8 3.5 ± 3.0 NS
Abciximab 19 20 NS
TIMI flow post-PCI
TIMI 2 4 3 NS
TIMI 3 19 19 NS
Peak CKMB 188 ± 102 378 ± 156 \0.001
Time to baseline
CMR (days)
4.3 ± 2.1 5.7 ± 2.0 0.03
Total infarct size (% of LV) 11.3 ± 7.3 24.4 ± 7.0 \0.001
MVO 5 22 \0.001
MVO (% of total infarct) 0.3 ± 1.1 12.3 ± 8.9 \0.001
EDV (ml/m2) 89 ± 22 104 ± 22 0.02
ESV (ml/m2) 49 ± 17 64 ± 19 0.007
Ejection fraction (%) 46.4 ± 8.4 38.9 ± 8.1 0.004
Values are presented as numbers or as mean ± standard deviation
LAD left anterior descending artery, LCx left circumflex artery,
RCA right coronary artery, TIMI thrombolysis in myocardial
infarction. PCI percutaneous coronary intervention
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in ejection fraction (b = -0.29 and b = -4.99, res-
pectively, P \ 0.01).
Discussion
Our study showed that intramyocardial hemorrhage
can be found in almost half of patients with
successfully revascularized acute myocardial infarc-
tion. The presence of IMH was associated with larger
infarcts, presence of MVO, higher left ventricular
volumes and lower ejection fraction, and the lack of
improvement at follow-up. Contrast-to-noise ratio
between (attenuated) core and (high) peripheral T2W
signal intensity was strongly related to markers of
infarct size, MVO and function. However, in our
study, it was not an independent predictor of func-
tional changes at follow-up.
T2-weighted imaging, edema and hemorrhage
Normal myocardium has low to intermediate signal on
T2W images, but increased regional water content,
such as infarct related edema, causes an increase in the
T2-relaxation time and T2W signal intensity [15].
Hemorrhage and the breakdown of oxygenated hemo-
globin also influence magnetic properties of the
surrounding tissue. The effects of hemoglobin degra-
dation have been extensively studied in patients with
cerebral hemorrhage; they are complex and strongly
dependent on the age of the hematoma and the
integrity of the erythrocyte membrane [8]. T2W signal
is high in the very early, hyperacute phase, but then
falls because of the paramagnetic effects of deoxyhe-
moglobin and intracellular methemoglobin [8]. Espe-
cially in the core of the hematoma, where there is
marked hypoxia, signal may remain very low for a
prolonged period of time [16]. Lotan et al. studied
IMH in a canine myocardial infarction model using
ex-vivo T2W [9]. They found areas of low signal
within the zone of increased signal that accurately
matched the location of macroscopic hemorrhage in
all animals but one (with a very small hemorrhage),
and no hypointense T2W regions in the animals
without hemorrhage. Hemorrhage size according to
CMR correlated closely to size determined from tissue
slices and according to labeled red blood cells. Basso
et al. recently compared in vivo and ex-vivo CMR to
histopathological findings in two patients that had
died 12 and 24 days after percutaneous revasculari-
zation, respectively [17]. Both patients had hemor-
rhagic infarcts, with massive bleeding at the core of
the infarct. Both in vivo and ex-vivo T2W showed
areas of low signal intensity within areas of high
signal intensity that corresponded to hemorrhage and
edema, respectively. Thus, although we have no direct
proof of the presence of hemorrhage in our patients,
we believe that these studies sufficiently show that
hemorrhage and hemoglobin breakdown leads to
T2W signal attenuation as documented in our study.
Our results are roughly in line with the results from
previous studies that used T2*(‘star’)-weighted gra-
dient-echo techniques to visualize IMH [10, 11].
Asanuma et al. found IMH in 9 of 24 (38%) patients
with reperfused anterior MI [10]. Patients with IMH
had larger enzymatic infarct size, more Q-wave
infarctions and less improvement in echocardio-
graphic wall motion score. Ochiai et al. showed
IMH in 13 of 39 (33%) patients with reperfused
infarction, and also found an association between
IMH, infarct severity and less improvement of
ventriculographic ejection fraction [11]. There are
no studies comparing T2W spinecho imaging to T2*-
weighted gradient-echo imaging for the assessment of
IMH, and, at this point, it is not clear which is the
optimal technique for its visualisation. Cardiac appli-
cation of both techniques has been validated in a
limited number of experimental and pathological
studies [9, 11, 18]. Although T2*-weighted gradient-
echo imaging is very sensitive to the paramagnetic
effects of the deoxyhemoglobin and methemoglobin,
it requires relatively long echo times that may degrade
image quality during cardiac imaging [8]. T2W
spinecho imaging has the advantage that it also
depicts infarct related edema, which has been shown
to correspond to the area at risk [19, 20]. In line with a
recent report by Friedrich et al., we found that mean
(single slice) T2W infarct area was (approximately
70%) larger than DE infarct area [20].
Clinical implications
Hemorrhagic myocardial infarction was rarely seen
in autopsy studies in the pre-reperfusion era, but
its reported incidence markedly increased after the
introduction of thrombolytic therapy [6, 21]. Later
studies showed that it also occurred after primary PCI
[10, 11]. The appearance of hemorrhage therefore
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depends on the coexistence of myocardial reperfusion
and microvascular damage in the setting of severe
myocardial ischemia [7, 17]. The large majority (81%)
of our patients with MVO also had IMH, and MVO size
in the 5 patients without IMH was very small (\ 1% of
total infarct size). Further more, our results suggest that
hemorrhage severity, as reflected by the degree of T2W
signal attenuation as contrast-to-noise ratio, is related
to infarct and MVO extent, but does not have
prognostic value beyond MVO. In early studies in the
mid-seventies, Kloner et al. already demonstrated that
extravasation of erythrocytes is one of the morpholog-
ical features found in areas of no-reflow [22]. This
close relation between MVO and IMH might explain
the lack of additional prognostic significance as seen in
our study. Figure 2 illustrates the co-existence of
edema, IMH and MVO in a patient who died 3 days
after inferoposterior myocardial infarction (patient
was not included in the study group).
The non-invasive assessment of IMH by CMR
might be used to indicate infarct severity and
underlying microvascular injury, e.g. in patients with
(moderate to severe) renal insufficiency, who have a
relative contra-indication against the use of gadolin-
ium compounds [23]. However, further study is
needed to define the optimum CMR technique to
assess IMH, and to determine the exact role of IMH
in the myocardial healing process.
Study limitations
Spatial coverage of the T2W images was limited as
we focused on the identification of hemorrhage in the
core of the infarct. As a result, we may have missed
regions of signal attenuation in adjacent slices in the
five patients with MVO but without IMH.
Signal-to-noise ratios are related to scan parameters
such as voxel size, and therefore our results may not be
directly applicable when other scanners are used.
The current breath-hold T2W spin-echo imaging
technique is limited by its sensitivity to artifacts
caused by cardiac or respiratory motion, as illustrated
by the considerable number of non-diagnostic images
in our study group (10% of long axis images, 20% of
short axis images). A recently proposed adaptation of
the technique to optimize performance has not yet
been evaluated in a clinical setting [24].
Conclusions
Intramyocardial hemorrhage was found in the major-
ity of patients with microvascular obstruction after
percutaneous revascularization for acute myocardial
infarction. It was closely related to markers of infarct
size, MVO and function, but, in this study, did not
have prognostic significance beyond MVO.
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Fig. 2 Microscopic slides at 2009 magnification after stan-
dard hematoxylin and eosin staining of three samples of the
heart of a 44-year-old man who died 3 days after admission
with acute inferoposterior infarction (patient not included in
the study group). (a) infarct core with necrotic cardiomyocytes
(interrupted arrow) and abundant erythrocytes (solid arrows),
(b) infarct border zone with edema (open arrow), (c) capillary
vessel with thrombus (asterisk) and plugged polymorphonu-
clear cells (circled arrow)
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